4.7 Article

Low-dose aspirin protects unexplained recurrent spontaneous abortion via downregulation of HMGB1 inflammation activation

Journal

FRONTIERS IN ENDOCRINOLOGY
Volume 13, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2022.914030

Keywords

aspirin; high mobility group box protein 1; unexplained recurrent spontaneous abortion; inflammation; pregnancy

Funding

  1. National Natural Sciences Foundation of China [32000642]
  2. Natural Science Foundation of Anhui Province [1908085MH244]
  3. Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences [2019PT310002]
  4. Research Fund of Anhui Institute of translational medicine [ZHYX2020A001, 2021zhyx-B16]

Ask authors/readers for more resources

This study found that the levels of HMGB1 were significantly higher in URSA patients, and low-dose aspirin can decrease the concentrations of HMGB1 and IFN-γ, providing a protective effect.
BackgroundHigh mobility group box protein 1 (HMGB1) is considered as a kind of sterile inflammatory mediators, which is an overexpression in patients with unexplained recurrent spontaneous abortion (URSA). Specific targeting effect of aspirin on HMGB1 has been revealed. Our previous studies have explored the application of HMGB1 as a therapeutic target of aspirin in URSA disease of mice model and human, but the dynamic process of aspirin downregulating HMGB1 concentration has not been demonstrated. MethodsFrom December 2018 to November 2020, women with URSA (n = 91) and control women (n = 90) with no history of recurrent abortion or adverse pregnancy were included in the Reproductive Medicine Center of the First Affiliated Hospital of Anhui Medical University. ELISA was applied to detect the concentrations of HMGB1 and IFN-gamma in the peripheral blood. Thirty-one URSA patients were monitored for low-dose aspirin treatment (2 and 4 weeks), the changes of HMGB1 and IFN-gamma concentrations in peripheral blood of URSA patients before and after using aspirin were compared, and pregnancy outcomes after aspirin treatment were followed up. ResultsThe levels of HMGB1 in peripheral blood were significantly higher in URSA patients compared with controls, decreasing trends of HMGB1 and IFN-gamma concentrations in plasma of URSA patients were observed after treatment with low-dose aspirin continuously, and the expression of HMGB1 was positively correlated with IFN-gamma. There were no birth abnormalities in the babies of the URSA patients treated with aspirin. ConclusionsHigh levels of HMGB1 may be one of the pathogenesis of URSA. Low-dose aspirin may provide protective effect on the HMGB1-triggered URSA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available